The Ca2+-activated K+ channel of intermediate-conductance: A molecular target for novel treatments?
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
The Ca2+-activated K+ channel of intermediate-conductance: A molecular target for novel treatments? / Jensen Skanning, B.; Strøbaek, D.; Olesen, Søren-Peter; Christophersen, P.
I: Current Drug Targets, Nr. 2, 2001, s. 401-422.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
Jensen Skanning, B, Strøbaek, D, Olesen, S-P & Christophersen, P 2001, 'The Ca2+-activated K+ channel of intermediate-conductance: A molecular target for novel treatments?', Current Drug Targets, nr. 2, s. 401-422.
APA
Jensen Skanning, B., Strøbaek, D., Olesen, S-P., & Christophersen, P. (2001). The Ca2+-activated K+ channel of intermediate-conductance: A molecular target for novel treatments? Current Drug Targets, (2), 401-422.
Vancouver
Jensen Skanning B, Strøbaek D, Olesen S-P, Christophersen P. The Ca2+-activated K+ channel of intermediate-conductance: A molecular target for novel treatments? Current Drug Targets. 2001;(2):401-422.
Author
Bibtex
@article{5592f59074c711dbbee902004c4f4f50,
title = "The Ca2+-activated K+ channel of intermediate-conductance: A molecular target for novel treatments?",
author = "{Jensen Skanning}, B. and D. Str{\o}baek and S{\o}ren-Peter Olesen and P. Christophersen",
year = "2001",
language = "English",
pages = "401--422",
journal = "Current Drug Targets",
issn = "1389-4501",
publisher = "Bentham Science Publishers",
number = "2",
}
RIS
TY - JOUR
T1 - The Ca2+-activated K+ channel of intermediate-conductance: A molecular target for novel treatments?
AU - Jensen Skanning, B.
AU - Strøbaek, D.
AU - Olesen, Søren-Peter
AU - Christophersen, P.
PY - 2001
Y1 - 2001
M3 - Journal article
SP - 401
EP - 422
JO - Current Drug Targets
JF - Current Drug Targets
SN - 1389-4501
IS - 2
ER -
ID: 166736